Several tumor cell intrinsic factors have been found to hamper T cell immunity, including the expression of checkpoint receptors, the expression and secretion of galectins, or indoleamine 2,3-dioxygenase (IDO) [8–11]. Here, IDO1 is linked to neoplasm.